levofloxacin has been researched along with Cardiac Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hibi, A; Kumano, Y | 1 |
| Budzik, JF; Dehecq, E; Ducoulombier, V; Houvenagel, E; Pascart, T | 1 |
| Al-Khadimi, Z; Chow, WA; Doroshow, JH; Frankel, P; Lawrence, J; Leong, L; Lim, D; Longmate, J; Margolin, K; Morgan, RJ; Raschko, J; Shibata, S; Somlo, G; Synold, TW; Tetef, ML; Twardowski, P; Yen, Y | 1 |
| Choné, C; Petitpretz, P; Trémolières, F | 1 |
| Cantu, M; Ferguson, D; Page, RL | 1 |
2 trial(s) available for levofloxacin and Cardiac Failure
| Article | Year |
|---|---|
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies.
Topics: Adult; Antibiotics, Antineoplastic; Cardiovascular Agents; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Razoxane; Sarcoma; Sepsis; Treatment Outcome | 2004 |
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Topics: Aged; Bronchitis, Chronic; Cefuroxime; Female; Heart Failure; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Treatment Outcome | 2007 |
3 other study(ies) available for levofloxacin and Cardiac Failure
| Article | Year |
|---|---|
Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Gram-Negative Bacterial Infections; Heart Failure; Humans; Levofloxacin; Male; Meropenem; Pulmonary Disease, Chronic Obstructive; Shock, Septic; Sphingobacterium; Thienamycins; Treatment Outcome | 2017 |
Spondylodiscitis due to Rhizobium radiobacter.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Catheter-Related Infections; Catheterization, Central Venous; Discitis; Drug Resistance, Multiple, Bacterial; Environmental Exposure; Female; Gram-Negative Bacterial Infections; Heart Failure; Humans; Immunocompromised Host; Levofloxacin; Lumbar Vertebrae; Lymphoma, Follicular; Rituximab; Tomography, X-Ray Computed | 2015 |
An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Comorbidity; Drug Therapy, Combination; Heart Failure; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Proton Pump Inhibitors | 2008 |